🇺🇸 FDA
Patent

US 7972813

Tetrodotoxin-resistant sodium channel alpha subunit

granted A61KA61K38/00

Quick answer

US patent 7972813 (Tetrodotoxin-resistant sodium channel alpha subunit) held by Vertex Pharmaceuticals Incorporated expires Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Jul 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 30 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K38/00